Showing results (1801-1810 of 5,064) with videos related to

Sort By:
Pageof 507
Multiple Sclerosis and Related Disorders|February 20, 2022
Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Tracy L Fabri, Julia O'Mahony, Giulia Fadda, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021Saba Naghavi, Aryan Kavosh, Iman Adibi, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Multiple sclerosis by phenotype in GermanyJohanna Engelhard, Denise M Oleske, Sarah Schmitting, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosisJoseph B Guarnaccia, Ann Cabot, Lore L Garten, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational ProgramMarco Salvetti, Sibyl Wray, Gereon Nelles, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosisJaidaa Mekky, Richard Wani, Sameh M Said, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysisMahdi Barzegar, Omid Mirmosayyeb, Narges Ebrahimi, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiencesClaudia H Marck, Assunta Hunter, Ernest Butler, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosisA A Toorop, Z Y G J van Lierop, E M M Strijbis, et al.
Pageof 507